
    
      Ascending dose design includes 6 dose levels ï¼ˆ25 mg, 75 mg, 150 mg, 300 mg, 450 mg and 600
      mg). Tolerance and safety data up to 14 days after dosing from all subjects of the previous
      cohort will be reviewed before proceeding to the next dose. Total duration of the study per
      subject is 12 weeks.
    
  